Bristol-Myers Squibb News

Kurse + Charts + Realtime	News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Orderbuch			Analysen
Historisch

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Aktion

Kurs + Chart

Chart (gross)

News + Adhoc

Bilanz/GuV

Termine

Strukturierte Produkte

Portfolio

Times + Sales

Chartvergleich

Analysen

Schätzungen

Profil

Watchlist

Börsenplätze

Realtime Push

Kursziele

Dividende/GV

Orderbuch

Analysen

Historisch

31.10.24	Bristol Myers Squibb Lifts FY24 Earnings View Above Market; Stock Up In Pre-market - Update (RTTNews)
31.10.24	Bristol-Myers Squibb Co. Q3 Profit Decreases, But Beats Estimates (RTTNews)
30.09.24	Prime Medicine Inks Strategic Research Collaboration And License Agreement With Bristol Myers Squibb (RTTNews)
30.09.24	Biotech Stocks Facing FDA Decision In October 2024 (RTTNews)
27.09.24	Bristol Myers Squibb's COBENFY Gains FDA Approval For Adult Schizophrenia Treatment (RTTNews)
25.09.24	2seventy, Bristol Myers Discontinue Enrollment In Phase 3 KarMMa-9 Study - Quick Facts (RTTNews)
05.09.24	Merck's Winrevair Approved For Pulmonary Arterial Hypertension In Canada (RTTNews)
02.09.24	Biotech Stocks Facing FDA Decision In September 2024 (RTTNews)
01.09.24	Weekly Biotech Buzz: BMRN Cuts Jobs, FDA Approves New Mpox Vaccine, MRK Halts 2 Keytruda Studies (RTTNews)
21.08.24	Bristol Myers : FDA Accepts SBLA For First-Line Treatment Of Unresectable Hepatocellular Carcinoma (RTTNews)
19.08.24	EMA Validates Bristol Myers Squibb's Application For CAR T Cell Therapy Breyanzi (RTTNews)
13.08.24	Evotec Secures $75 Mln In Milestone Payments From Bristol Myers Amid Pipeline Advancements (RTTNews)
11.08.24	Weekly Review: ANTX Downsizes, ALDX Aces Dry Eye Disease Trial, FDA Oks 1st Epinephrine Nasal Spray (RTTNews)
26.07.24	Bristol Myers Squibb Raises 2024 Non-GAAP Guidance (RTTNews)
26.07.24	Bristol-Myers Squibb Co. Q2 Profit Decreases, But Beats Estimates (RTTNews)
19.07.24	Bristol Myers Squibb Receives EMA Validation For Opdivo Plus Yervoy For Treatment Of HCC (RTTNews)
05.06.24	I-Mab Inks Partnership With Bristol Myers Squibb To Evaluate Givastomig In Combination Study (RTTNews)
03.06.24	Bristol Myers' 3 Breyanzi Trials Show Consistent Benefit Across B-Cell Malignancies (RTTNews)
06.05.24	Bristol Myers Says Type II Variation Application For Opdivo + Yervoy Granted EMA Validation (RTTNews)
30.04.24	Biotech Stocks Facing FDA Decision In May 2024 (RTTNews)
29.04.24	Repertoire Immune Medicines In Strategic Partnership With Bristol Myers Squibb (RTTNews)
26.04.24	Bristol Myers: CHMP Recommends Approval Of Opdivo In Combination With Cisplatin And Gemcitabine (RTTNews)
25.04.24	Bristol Myers Squibb Posts Loss In Q1; Updates 2024 Non-GAAP EPS Guidance (RTTNews)
25.04.24	Bristol-Myers Squibb Co. Q1 Earnings Summary (RTTNews)
05.04.24	Bristol Myers, 2seventy Bio Get FDA Nod For Abecma For Relapsed Multiple Myeloma Patients (RTTNews)
01.04.24	Zai Lab: Bristol Myers' KRYSTAL-12 Confirmatory Trial With Adagrasib Meets Meets Primary Endpoint (RTTNews)
19.03.24	Perspective Therapeutics Inks Clinical Trial Collaboration Agreement With Bristol Myers (RTTNews)
18.03.24	Bristol Myers Squibb Completes Acquisition Of Karuna Therapeutics - Quick Facts (RTTNews)
28.02.24	Biotech Stocks Facing FDA Decision In March 2024 (RTTNews)
23.02.24	Bristol Myers Squibb: Approx. 86% Of RayzeBio Common Stock Validly Tendered As Of Expiration Time (RTTNews)
14.02.24	Bristol-Myers' Augtyro Receives Priority Review Status From FDA (RTTNews)
12.02.24	Bristol Myers Squibb, RayzeBio Report Expiration Of HSR Act Waiting Period (RTTNews)
02.02.24	Bristol-Myers Squibb Guides FY24 Adj. EPS Above Estimates As Q4 Results Top Estimates - Update (RTTNews)
02.02.24	Bristol-Myers Squibb Co. Q4 Profit Decreases, but beats estimates (RTTNews)
30.01.24	Bristol-Myers Says Regulatory Applications For Breyanzi Accepted By FDA, Japan's MHLW (RTTNews)
26.01.24	Bristol-Myers's Abecma Receives CHMP Recommendation For Market Authorization (RTTNews)
23.01.24	Bristol Myers Squibb Completes Acquisition Of Mirati For Upto $5.8 Bln (RTTNews)
26.12.23	Bristol Myers Squibb To Acquire RayzeBio For $62.50/share In All-cash Deal (RTTNews)
22.12.23	Bristol Myers Squibb To Acquire Karuna Therapeutics For $330/share Cash (RTTNews)
14.12.23	Terray, Bristol Myers Squibb Join To Identify Small Molecule Therapeutics Using TNova Platform (RTTNews)
14.12.23	Terray Therapeutics Announces Multi-Target Collaboration with Bristol Myers Squibb (PR Newswire)
07.12.23	Bristol Myers Squibb To Repurchase Additional $3 Bln Of Shares (RTTNews)
05.12.23	Bristol Myers: FDA Accepts SBLA For Opdivo Combination For Priority Review (RTTNews)
28.11.23	Avidity Biosciences Inks Global Licensing And Research Collaboration Deal With Bristol Myers Squibb (RTTNews)
28.11.23	Avidity Biosciences Announces Expansion of Cardiovascular Collaboration with Bristol Myers Squibb for up to Five Targets Utilizing Avidity's Proprietary AOC™ Platform Technology (PR Newswire)
20.11.23	Bristol Myers Squibb, 2seventy Bio Issue Update On FDA Review For Abecma (RTTNews)
01.11.23	Bristol Myers Squibb Elects Christopher Boerner To Serve As Chair Of Board (RTTNews)
30.10.23	Karyopharm Enters Clinical Trial Collaboration, Supply Agreement With Bristol-Myers Squibb (RTTNews)
28.10.23	Biotech Stocks Facing FDA Decision In November 2023 (RTTNews)
26.10.23	Bristol-Myers Squibb Boosts FY23 Adj. EPS Outlook As Q3 Adj. EPS Tops Estimates (RTTNews)

Aktien Top/Flop

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

Part Grp Hldg	1’263.50	2.89 %	K V
Sonova Hldg	312.10	2.66 %	K V
Novartis	93.68	2.32 %	K V
Geberit	526.80	1.97 %	K V
Roche Hldg G	254.30	1.27 %	K V
Kuehne+Nagel Int	209.50	0.72 %	K V
UBS Group	28.30	0.57 %	K V
Givaudan	3’933.00	0.36 %	K V
Nestle	76.00	0.05 %	K V
Lonza Grp	521.40	-0.04 %	K V

mehr

22.11.24		Dow Jones aktuell: Dow Jones zum Ende des Freitagshandels in der Gewinnzone
22.11.24		SIX-Handel: SLI zeigt sich zum Ende des Freitagshandels fester
22.11.24		Pluszeichen in Zürich: SMI zum Ende des Freitagshandels mit grünem Vorzeichen
22.11.24		Gute Stimmung in Europa: Anleger lassen STOXX 50 letztendlich steigen
22.11.24		Deutsche Bank AG: Novartis-Aktie erhält Hold
22.11.24		Freitagshandel in New York: Dow Jones zum Start des Freitagshandels fester
22.11.24		Optimismus in Europa: So entwickelt sich der Euro STOXX 50 am Freitagnachmittag
22.11.24		Pluszeichen in Europa: STOXX 50 notiert im Plus

22.11.24

Dow Jones aktuell: Dow Jones zum Ende des Freitagshandels in der Gewinnzone

22.11.24

SIX-Handel: SLI zeigt sich zum Ende des Freitagshandels fester

22.11.24

Pluszeichen in Zürich: SMI zum Ende des Freitagshandels mit grünem Vorzeichen

22.11.24

Gute Stimmung in Europa: Anleger lassen STOXX 50 letztendlich steigen

22.11.24

Deutsche Bank AG: Novartis-Aktie erhält Hold

22.11.24

Freitagshandel in New York: Dow Jones zum Start des Freitagshandels fester